IFNA1 and hepatocellular carcinoma: The cumulative HCC development rate at 1-, 3- and 5-year were 1.5%, 10% and 19% for the PEG-IFN/RBV group and 1.5%, 10% and 12% for the DCV/ASV group, respectively (P = 0.886) (Fig 2A).